Drugs / FMT capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04130763 | Dec 2019 → Feb 2023 | digestive system cancer | Peking University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMT capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04130763 ↗ |
| Route | Oral | “via oral capsules” PMID 41871875 ↗ Mar 2026 |